160 related articles for article (PubMed ID: 23800003)
1. Can unknown predisposition in familial breast cancer be family-specific?
Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
[TBL] [Abstract][Full Text] [Related]
2. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
6. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM
PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423
[TBL] [Abstract][Full Text] [Related]
7. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
8. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
Wen H; Kim YC; Snyder C; Xiao F; Fleissner EA; Becirovic D; Luo J; Downs B; Sherman S; Cowan KH; Lynch HT; Wang SM
BMC Cancer; 2014 Jun; 14():470. PubMed ID: 24969172
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
[TBL] [Abstract][Full Text] [Related]
10. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.
Campbell IG; Choong D; Chenevix-Trench G;
Breast Cancer Res; 2004; 6(4):R366-71. PubMed ID: 15217503
[TBL] [Abstract][Full Text] [Related]
11. FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.
Park DJ; Odefrey FA; Hammet F; Giles GG; Baglietto L; ABCFS ; MCCS ; Hopper JL; Schmidt DF; Makalic E; Sinilnikova OM; Goldgar DE; Southey MC
Breast Cancer Res Treat; 2011 Dec; 130(3):1043-9. PubMed ID: 21858661
[TBL] [Abstract][Full Text] [Related]
12. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer.
Lynch H; Synder C; Wang SM
Breast J; 2015; 21(1):67-75. PubMed ID: 25472498
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres.
Yanowsky K; Barroso A; Osorio A; Urioste M; Benitez J; Martinez-Delgado B
Breast Cancer Res Treat; 2012 Aug; 134(3):1337-43. PubMed ID: 22752289
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer susceptibility variants alter risks in familial disease.
Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM
Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.
Harvey SL; Milne RL; McLachlan SA; Friedlander ML; Birch KE; Weideman P; ; Goldgar D; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2011 Dec; 130(3):1057-61. PubMed ID: 21850394
[TBL] [Abstract][Full Text] [Related]
19. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
Bonadona V; Lasset C
Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
Lara K; Consigliere N; Pérez J; Porco A
Biol Res; 2012; 45(2):117-30. PubMed ID: 23096355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
